Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral-Care Innovation Rooted in Trans-Pacific Alder Research

RegulatoryOLTIS DENTAL-XPositive

AI Analysis

Summary

Dr. Oregonin Inc. announced completion of U.S. FDA registration for OLTIS DENTAL-X, an oral-care product based on oregonin derived from 1974 Oregon State University research and 27 years of South Korean natural-product development.

Outcome Details

FDA registration completed

Importance:5/10

Sentiment:

0.60

FDAoral carebotanicalnatural productregistration

Related Companies

$NAII

Read the original article

Published by PR Newswire Biotech on October 6, 2026 5:50 AM

Read Original